Vanguard Group Inc Ptc Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,178,822 shares of PTCT stock, worth $507 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,178,822
Previous 9,125,134
0.59%
Holding current value
$507 Million
Previous $339 Million
22.39%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding PTCT
# of Institutions
258Shares Held
77.4MCall Options Held
179KPut Options Held
536K-
Black Rock Inc. New York, NY7.77MShares$429 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$409 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$352 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$265 Million0.04% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$182 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.95B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...